Myriad Genetics | MYGN - Nettoeinkommen

Aktienkurs
5.08
Täglich Wechseln
0.08 1.60%
Monatlich
9.48%
Jährlich
-31.35%
Q2 Prognose
4.23




Nettoeinkommen Veränderung Datum
Agilent USD 305M 129M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio-Rad Laboratories USD -341.9M 659.7M 2025-09
Bruker USD 26M 88.4M 2025-12
Danaher USD 1.2B 289M 2025-12
Illumina USD 334M 184M 2025-12
J&J USD 5.24B 119M 2026-03
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Pacific Biosciences Of California USD -40.37M 2.37M 2025-12
Quest Diagnostics USD 245M 0 2025-12
Quidel USD -733M 477.6M 2025-09
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Standard Biotools USD 19.28M 53.97M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Veracyte USD 41.15M 22.01M 2025-12
Waters USD 225.21M 76.29M 2025-12